Checked
Neogen Corp
Nasdaq: NEOG · In Vitro & In Vivo Diagnostic Substances · Lansing, MI
- Revenue
- $870.4M
- -2.7% vs. prior year
- Net income
- -$7.9M
- -0.9% net margin
- Total assets
- $3.35B
- Diluted EPS
- -$0.04
Company details
As reported to the SEC
- SEC CIK
- 711377
- Stock
- Nasdaq: NEOG
- Legal Entity Identifier (LEI)
- 549300HJT9FC36N4UW43
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances (2835)
- Headquarters
- 620 Lesher Place, Lansing, MI 48912
- Incorporated in
- Michigan
- Fiscal year end (SEC record)
- May 31
- Filer status
- Large accelerated filer
- Phone
- (517) 372-9200
- Employer ID (EIN)
- 38-2367843
- Last annual report
- 07/30/2026
- Last quarterly report
- 10/07/2026
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 05/31/2026 | 05/31/2025 | 05/31/2024 | 05/31/2023 | 05/31/2022 |
|---|---|---|---|---|---|
| Revenue | $870.4M | $894.7M | $924.2M | $822.4M | $527.2M |
| Gross profit | $408.5M | $421.4M | $463.9M | $406M | $243M |
| Operating income | -$21.6M | -$1.06B | $58.6M | $37.52M | $58.62M |
| Net income | -$7.9M | -$1.09B | -$9.4M | -$22.87M | $48.31M |
| Diluted earnings per share | -$0.04 | -$5.03 | -$0.04 | -$0.12 | $0.45 |
| Research and development | $18.4M | $21.1M | $22.5M | $26.04M | $17.05M |
| Total assets | $3.35B | $3.44B | $4.55B | $4.55B | $992.9M |
| Total liabilities | $1.25B | $1.37B | $1.4B | $1.42B | $105.6M |
| Shareholders' equity | $2.09B | $2.07B | $3.14B | $3.13B | $887.4M |
| Cash and cash equivalents | $185.5M | $129M | $170.6M | $163.2M | $44.47M |
| Long-term debt | $793.7M | $874.8M | $888.4M | $885.4M | Not reported |
| Cash from operations | $83.2M | $58.2M | $35.3M | $41.03M | $68.04M |
Federal and state records filed under the name Neogen Corp
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Neogen CorporationLansing, MI | 3 | 3 |
FDA recalls
Recalls of food, drugs and devices reported to the FDA
Swipe the table sideways to see more columns.
Trucking registrations
Motor carrier registrations with the Federal Motor Carrier Safety Administration
Swipe the table sideways to see more columns.
| Carrier | USDOT | Power units |
|---|---|---|
| Neogen CorporationLansing, MI | 2446000 | 3 |
Subsidiaries
50 companies that Neogen Corp owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| Acumedia Manufacturers, Inc. | SEC 10-K |
| CAP IM Supply, LLC | SEC 10-K |
| CAP Supply, LLC | SEC 10-K |
| Chem-Tech, Ltd. | SEC 10-K |
| Delf (UK) Limited | SEC 10-K |
| Falcon New OpCo, LLC | SEC 10-K |
| GeneSeek Australia | SEC 10-K |
| GeneSeek Canada Properties I, Inc. | SEC 10-K |
| GeneSeek Canada, Inc. | SEC 10-K |
| GeneSeek UK Ltd | SEC 10-K |
| Geneseek Inc. | SEC 10-K |
| Genetic Veterinary Services, LLC | SEC 10-K |
| Hacco, Inc. | SEC 10-K |
| Megazyme, Ltd. | SEC 10-K |
| NeoG Corp. | SEC 10-K |
| Neogen Argentina S.A. | SEC 10-K |
| Neogen Asia (Thailand) Co, Ltd | SEC 10-K |
| Neogen Australasia Pty Limited | SEC 10-K |
| Neogen Bio-Scientific Technology (Shanghai) Co., Ltd. | SEC 10-K |
| Neogen Chile SpA | SEC 10-K |
| Neogen Colombia SAS | SEC 10-K |
| Neogen DR, S.r.l. | SEC 10-K |
| Neogen Europe Limited | SEC 10-K |
| Neogen Food Safety Brazil, Ltda | SEC 10-K |
| Neogen Food Safety Canada Corporation | SEC 10-K |
| Neogen Food Safety Corporation | SEC 10-K |
| Neogen Food Safety Euro Holdings, Ltd | SEC 10-K |
| Neogen Food Safety Switzerland GmbH | SEC 10-K |
| Neogen Food Safety UK Holdings, Ltd | SEC 10-K |
| Neogen Food Safety US HoldCo Corporation | SEC 10-K |
| Neogen Food and Animal Security (India) PVT, LTD | SEC 10-K |
| Neogen Germany GmbH | SEC 10-K |
| Neogen Guatemala S.A. | SEC 10-K |
| Neogen Ireland Limited | SEC 10-K |
| Neogen Italia S.r.l. | SEC 10-K |
| Neogen Japan Kabushiki Kaisha | SEC 10-K |
| Neogen Korea Limited | SEC 10-K |
| Neogen Latinoamerica S.A.P.I. DE C.V. | SEC 10-K |
| Neogen Poland Sp. Zoo | SEC 10-K |
| Neogen Properties II, LLC | SEC 10-K |
| Neogen Properties III, LLC | SEC 10-K |
| Neogen Properties IX, LLC | SEC 10-K |
| Neogen Properties V, LLC | SEC 10-K |
| Neogen Properties VI, LLC | SEC 10-K |
| Neogen Properties VII, LLC | SEC 10-K |
| Neogen Uruguay S.A. | SEC 10-K |
| Neogen do Brasil Productos Para Labratories LTDA. | SEC 10-K |
| Rogama Industria e Comercio Ltda. | SEC 10-K |
| US Genomics Headco LLC | SEC 10-K |
| WHERE INCORPORATED | SEC 10-K |
Recent filings
135 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
64 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Neogen Corp in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other in vitro & in vivo diagnostic substances
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Idexx Laboratories IncIDXX | Westbrook, ME | $4.3B | $1.06B |
| QuidelOrtho CorpQDEL | San Diego, CA | $2.73B | -$1.13B |
| Lantheus Holdings, Inc.LNTH | Bedford, MA | $1.54B | $233.6M |
| Myriad Genetics IncMYGN | Salt Lake City, UT | $824.5M | -$365.9M |
| Intellia Therapeutics, Inc.NTLA | Cambridge, MA | $67.67M | -$412.7M |
| Trinity Biotech PLCTRIB | Wicklow, Ireland | $61.55M | -$31.79M |
| Alpha Teknova, Inc.TKNO | Hollister, CA | $40.52M | -$17.26M |
| Immucell CorpICCC | Portland, ME | $27.64M | -$1.04M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Neogen Corp's CIK number?
- Neogen Corp's SEC Central Index Key (CIK) is 711377.
- What is Neogen Corp's stock ticker?
- Neogen Corp trades as Nasdaq: NEOG.
- What was Neogen Corp's revenue?
- Neogen Corp reported revenue of $870.4M for the fiscal year ended May 31, 2026, -2.7% from the year before.
- When does Neogen Corp's fiscal year end?
- Neogen Corp's fiscal year end on file with the SEC is May 31; its most recent fiscal year ended May 31, 2026.
- Where is Neogen Corp headquartered?
- Neogen Corp's principal executive office on file with the SEC is in Lansing, MI.
- What companies does Neogen Corp own?
- Neogen Corp lists 50 subsidiaries in its SEC filings and other public records, including Acumedia Manufacturers, Inc., CAP IM Supply, LLC, CAP Supply, LLC.
- Does Neogen Corp sponsor H-1B visas?
- Department of Labor records show 3 certified H-1B filings and 3 certified PERM filings under the name Neogen Corp.
- Has Neogen Corp had any FDA recalls?
- The FDA lists 10 recalls with Neogen Corp as the recalling firm. The latest started Oct 8, 2024.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026